[1]
Y. Mushlih, K. A. Suryoadji, and F. Prasetyawaty, “Survival Rate of Gemcitabine Monotherapy after Prior Platinum-based Chemotherapy for Metastatic Bladder Cancer”, Cermin Dunia Kedokteran, vol. 49, no. 12, pp. 693–701, Dec. 2022.